DV
Dividend Vision

KPTI — Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc (KPTI)

Total return is -99.2% over the past 12.8 years, 543.0 points behind SPY at 443.8%. Its deepest 1-year drawdown was 82.1%.

KPTI is a single-stock equity holding in Karyopharm Therapeutics Inc., a biopharmaceutical company, rather than a diversified ETF. The holding does not currently distribute dividends, resulting in no yield profile or distribution frequency. This concentrated position is suited for investors seeking exposure to a specific biotech company rather than those pursuing regular dividend income or broad market diversification.

KPTI key facts

Asset type
Stock
Asset class
Equity
Inception date
11/06/2013
Last close
$2.02
Market cap
$169,292,192
Average volume
877400.0
Beta
0.807
Payout ratio
0.0
Forward P/E
0.0
EPS
$-12.91